Prestige News

Total 79
Number Thumbnail Title Author Date Votes Views
79 Prestige Biopharma Participates in CPHI Milan 2026 to Expand Global Partnerships
김** | 2026.10.07 | Votes 0 | Views 710
김** 2026.10.07 0 710
78 Prestige Biopharma IDC's Taeheung Kang, Director of Drug Development Division: 'Additional Pipelines Ready… Accelerating Resear
김** | 2026.10.01 | Votes 0 | Views 738
김** 2026.10.01 0 738
77 Prestige Biopharma Appoints Neil O’Connor as Board Director, Strengthening Expertise in CMC and Quality Management
김** | 2026.09.30 | Votes 0 | Views 623
김** 2026.09.30 0 623
76 Prestige Biopharma Receives Brazilian Marketing Authorization for Herceptin Biosimilar Tuznue
김** | 2026.09.28 | Votes 0 | Views 905
김** 2026.09.28 0 905
75 Prestige Biopharma’s Tuznue Receives Marketing Authorization in Trinidad and Tobago
김** | 2026.09.18 | Votes 0 | Views 1060
김** 2026.09.18 0 1060
74 Prestige Biopharma IDC Obtains ISO 14001 and ISO 45001 Certifications
김** | 2026.09.17 | Votes 0 | Views 845
김** 2026.09.17 0 845
73 Prestige Biopharma Successfully Concludes ‘Prestige Symposium’ on Aging
김** | 2026.09.09 | Votes 0 | Views 1401
김** 2026.09.09 0 1401
72 Prestige Biopharma IDC CEO Ko Sang-seok Purchases Company Shares on the Open Market
김** | 2026.09.03 | Votes 0 | Views 1766
김** 2026.09.03 0 1766
71 Prestige Biopharma’s Tuznue Secures Brazilian GMP Certification, Supporting Latin American Approval Process
김** | 2026.08.25 | Votes 0 | Views 2396
김** 2026.08.25 0 2396
70 Prestige Biopharma Files Patent Application for TASA™, a Blood-Based Pancreatic Cancer Diagnostic Platform
김** | 2026.08.12 | Votes 0 | Views 2417
김** 2026.08.12 0 2417